Clinical Trials Logo
  1. Home
  2. Dysgeusia
  3. NCT04629560

Miracle Fruit Powder for the Treatment of Taste Alterations Secondary to Chemotherapy

Dysgeusia Clinical Trial

Official title:
Miracle Fruit Powder for the Treatment of Taste Alterations Secondary to Chemotherapy

Clinical Trial Summary

Purpose and Objective: Compare the incidence of taste alteration in treatment vs. control arms and Compare weight loss in treatment vs. control arms

Clinical Trial Description

After patients is explained all potential risks and study guidelines all patients will be given an ICF to sign if they wish to participate. Once the ICF has been signed by patient approximately between 3-5 days will undergo a screening to determine protocol eligibility. If patients qualifies (eligible) for study patients will be randomly assigned either to the miracle fruit intervention or to supportive measures at first and later participants will cross over to the other intervention ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04629560
Study type Interventional
Source Mt. Sinai Medical Center, Miami
Contact
Status Completed
Phase Early Phase 1
Start date August 18, 2008
Completion date June 20, 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT05812209 - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Completed NCT01097915 - Gustin Gene Polymorphism and 6-n-propylthiouracil (PROP) Taste
Recruiting NCT03210441 - Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment in Patients Affected by Breast Cancer N/A
Completed NCT00036881 - Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer Phase 3
Not yet recruiting NCT06311877 - Effects of Flavor Modification for Management of Radiation Induced Dysgeusia N/A
Recruiting NCT04791436 - Oral and Olfactory Complications of Recovered COVID-19 Patients
Recruiting NCT04384042 - Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study
Completed NCT04390165 - Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study
Completed NCT05868850 - Application of Auricular Point Sticking in Patients With Taste Alteration N/A
Recruiting NCT05486260 - Effect of Dried Miracle Berry on the Olfactory-gustative Perception in Malnourished Cancer Patients N/A
Withdrawn NCT05760079 - Lactoferrin for COVID-19-Induced Taste or Smell Abnormality N/A
Completed NCT04473157 - COVID-19 in Patients With Anosmia in Egypt
Recruiting NCT02304913 - Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy N/A
Completed NCT01596634 - Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy N/A
Completed NCT04543175 - Taste Disorders and Their Relation to BMI, FFQ, and EORTC QLQ-BR23 in Breast Cancer Patients During Chemotherapy.
Completed NCT01540045 - Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
Recruiting NCT02475928 - Zinc Supplementation in Cirrhotic Patients N/A